{"name":"COUR Pharmaceutical Development Company, Inc.","slug":"cour-pharmaceutical-development-company-inc","ticker":"","exchange":"","domain":"courdevelopmentcompany.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNbDg5RnNsTTBsemtNSmlISlh4NE4zcjlobUx0Y1FDejZmMG1MRGFKWHNJcjI5R3RSNVFna2s5c2JpS3lSUUw0NzlBMkJ6X19ycmVUck9aS3dZalVvcl91YmQtVG15VkJQZDB3X1VQUDRDVGRleFVpY2kxa252bXI1TUxuLWh6UHc?oc=5","date":"2026-03-03","type":"trial","source":"Yahoo Finance","summary":"COUR Pharma Announces Positive One-Year Results from the Phase 2a Study of CNP-104 in Primary Biliary Cholangitis - Yahoo Finance","headline":"COUR Pharma Announces Positive One-Year Results from the Phase 2a Study of CNP-104 in Primary Biliary Cholangitis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOMDZyV1E0ZHBpb2FQTy11ZG1Remc3bmlCMllfMExzN1l2UHZ0ZzEzVEJJamRwME5IdVhVeW8xZGViWXNBNkdOeEw1RGhwazVmbE00bDJrQ09BbzJyU3JobTBpcHVoTkFrRFJFdVU3ZE9Ubm8yZXhuMk5HOXg4MGFkUUE4a3h6cHM?oc=5","date":"2026-01-21","type":"regulatory","source":"JD Supra","summary":"Supreme Court Takes Up Hikma v. Amarin: Induced Infringement and Skinny Labels in the Crosshairs - JD Supra","headline":"Supreme Court Takes Up Hikma v. Amarin: Induced Infringement and Skinny Labels in the Crosshairs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxPRUUwNDZrRnpiMThFemdqWUNtbkItZlA0WXVIOXZXcmR6Y2Q3M096WGRJWUpSRTg1T3hBWkZLeW9uTGFFRTh3dGNHWTdsNU5ac0t1YUE4UDlISDNjak5qM2tWTmdjOVRZR3FYY2gzdktHdjZzZW85V2hyWkFSTHI0N2VTZ2FmcTVZbTFtMWloSXEzWkJiSWkzRWhLYXkyMkMySVFPaW4tTDFVWFFXRFNGUDlSYzlmQWc2RndzZkxhV0FPUGs5UUw4UlpTQU9vd205NEEwdjlXaEFHbkQ0eEdz?oc=5","date":"2025-12-16","type":"pipeline","source":"scanx.trade","summary":"Alembic Pharmaceuticals Challenges ₹421.68 Crore Supplementary Invoices in Gujarat High Court - scanx.trade","headline":"Alembic Pharmaceuticals Challenges ₹421.68 Crore Supplementary Invoices in Gujarat High Court","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQMXpGdDZUei1lcWhzM2VfU3VaaW8xNnctYmNZZ1BtX0FnRDEwbW9Hb09jNlFEXzFmblViclRaMkxoSnF1STMzcEFiUWRRSWZrZG51SjZhYTJmanpVbnJMR21MbW5odTRlVXVyd3VZWGU4VHN4Tm92NFlBY2ZKeVBtSWZscUljN2xBQmJaR1FaMS1QWnoxUkZXQ3VaaW1QeVp1QkoxU2hFd2p6dWdxQ2dJ?oc=5","date":"2024-12-03","type":"deal","source":"BioSpace","summary":"Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M - BioSpace","headline":"Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNSHdNalpLcS13cHFHMU16OWdyejJlSXJ5ZUtNNWQyajRpeUR3STZIc2NWTWxVdTJfWDBGUlpKVGtnNlR2bWo5eGo4bDc1QlZxMGVKN0g2SzBFVUFwWk9nbWlrc2xYWXNBVkd6dVN2V184eUdKb2tzSXlpckVIRzFfSnVIYWpScWNBelNSYllrT21iYWlveWNZSHRLUUVxOVY4?oc=5","date":"2024-11-23","type":"pipeline","source":"Urbanize Chicago","summary":"COUR Pharmaceuticals signs 50,000 square foot lease at Evanston Labs - Urbanize Chicago","headline":"COUR Pharmaceuticals signs 50,000 square foot lease at Evanston Labs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOSzRLbE9HdGUtbFk0MmtWMGY1VkxKSVFUa2labUUyUkMtTy1QaERHeG9GMXViWW5BTTA3SXljUzQ2dHdKQU10bWQ0bURuVTN4NGZiVmtvQVVBTjl4SVZuSS1jcDM3cW1fNm5PYnppaml1Uk5kODlIOTk0anFydWpmM2FNWUxNQ0p3QUxYZWhRRmxiSXpILVd3ZXRFbkY1NmdlSkY0?oc=5","date":"2024-06-03","type":"pipeline","source":"Drug Target Review","summary":"Treating immune-mediated diseases with nanoparticles - Drug Target Review","headline":"Treating immune-mediated diseases with nanoparticles","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPV0ZBbDd0ODJuVU01aDJKMGlfaUMyX0pZLVhOd3JWdUVkNS1xaUExT1I0UUY1cS0zY042U0twRjkxSk1zTFY4eEUzZVNJNTNoUzR0N3l3ZUxlU3FCX0h5Z0MwWjNVc3dPY3o4ZWVfeUhqVTNIWjU0b1pvN3M3SkpzamZlaVM1dmtQX2RHaEZn?oc=5","date":"2024-01-30","type":"pipeline","source":"statnews.com","summary":"Cour Pharmaceuticals, a biotech taking aim at autoimmune diseases, raises $105 million - statnews.com","headline":"Cour Pharmaceuticals, a biotech taking aim at autoimmune diseases, raises $105 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQVFR6d1NDa3BjT0wtLXNlSjFGS2x6WFF3ZWVTZnBLVGhXbzd5cGtjUWlabG15Rkw3TjVZeFFRcFZySHdZMlB5WGtFeDJRT19LaHZiV25CYmg4RjdXeVVEMHFnekN0eE1TRTlMLUJRX3VuTW1vZGxRMXNDR1pSU1FXcmc1N2RndGRpZndJM1RLSVdLNzJBV0lWcDg5bFc?oc=5","date":"2024-01-30","type":"pipeline","source":"BioPharma Dive","summary":"Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease - BioPharma Dive","headline":"Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPX3QzNmlWYzdoTGNYazRSQUlzem9mSmtJNzdpM29UaGp6dGg3Rkc1cl9Ub0VPY2VZRmNSOU9lNUNvTTJQejdDTE5LLVhDZUVzby01VUZhVFhhaHlobnFheVdvT1JQNy1jWDEya2IwS3V5UzhhRXVzbEhBZGtuZWRELTVTWDRQazVzX3VxUHBZdw?oc=5","date":"2024-01-30","type":"pipeline","source":"C&EN","summary":"Roche, Pfizer, Bristol Myers back immune disease firm Cour Pharmaceuticals - C&EN","headline":"Roche, Pfizer, Bristol Myers back immune disease firm Cour Pharmaceuticals - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNWjZIcFBUVEQwdllyaU1hMTRTWVBCRVp5djcyd3MwM1NiZEFLMTZ2VFUwdGlsWkloeVcxUUlZUk01SGdDWFN3UjBMSmhDSUJSWkpCYlFuanFmVUc3bEdfZFlvVnV2RlVQZDVYSlJTbVB5eDZLbEprWk9ldXRwN2hUaUMwRXZQSkZSaURPNzF0OTZnS0N5NzdjdGdrbkc5Z0d0eGJleERtc2VoVEpCTW9yXzh1WFZuREgtOVVFUzRNR0Z2RU9pWGVfUUxmVkYxeXBPeXl6allPMUI4eE0?oc=5","date":"2024-01-30","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Light My Fire: COUR Raises $105M Series A to Advance Tolerogenic Nanoparticles for Autoimmunity - Genetic Engineering and Biotechnology News","headline":"Light My Fire: COUR Raises $105M Series A to Advance Tolerogenic Nanoparticles for Autoimmunity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxOLTI4M0VZbTk2WTBWQjlvUUtCVFlrRFd2QlZfN0JrdkJSV2RzdDVzQjA1MHFYNFd2UUFLWnBIcGc2ZFdLRWpLVTFvSURqYmphTGlpQjVFYjJKMnJlMzhpcVozWUtoLWpxSGl4NFlUM1hHYXhUQlhwU2YzelhuWnVDMW5hcDRQQzF3eHRBT25UaTlHZFY2ZVlxQURJa2FOcmY4Yi1GTG1BeXl4UjQybGlsTllHZUduNzFhNmhZNEVLQzU4VlE5YXNhYjJwRWJoTVdManlZNVU0WlZkczFxRVJmbHRMR20yeDdWRENDcERVUnhBTFBiWkZKVUE1ZUxpM2dUZ21zblE3LUxmbmhydVlFdkRR?oc=5","date":"2024-01-30","type":"pipeline","source":"globenewswire.com","summary":"COUR Pharmaceuticals Secures $105 Million in Series A - globenewswire.com","headline":"COUR Pharmaceuticals Secures $105 Million in Series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOeGl4SUNuNnlTdGkwekstVkFkNVBEa2gwb1hKcS11Ny1FZFpHR1NGRmhncEdmejltSEhyTzFDNktfMXdPb0dxOHhoMTltbi1mVzc5UjcybkQtckJ4RXNxN3VxOUlNVG0taWtTNW9sWWNSeF9taFd0V0RhWjFjS0txZVV1YlQzTWNETWNVcWJnME5WSlhoTXBXTWNmbGRjQWJEbHZNdERiQzVCSVlBRWJmaG1LYU10NXIwQXpPSFg5YWRZZjJNVlE?oc=5","date":"2022-09-07","type":"pipeline","source":"PR Newswire","summary":"COUR Pharmaceuticals Announces $30M Financing Led by Alpha Wave Ventures - PR Newswire","headline":"COUR Pharmaceuticals Announces $30M Financing Led by Alpha Wave Ventures","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}